Buch, Englisch, 89 Seiten, Format (B × H): 183 mm x 260 mm, Gewicht: 402 g
Reihe: Neuroscience and Respiration
Buch, Englisch, 89 Seiten, Format (B × H): 183 mm x 260 mm, Gewicht: 402 g
Reihe: Neuroscience and Respiration
ISBN: 978-3-030-03869-4
Verlag: Springer International Publishing
This book describes various aspects of current scientific interest in clinical developments and management of pulmonary pathologies. Non-communicable and communicable disorders are tackled. Chronic disorders of an inflammatory background, such as COPD and asthma, often overlapping, diagnostically and therapeutically misguided and always difficult to manage, are in focus due to an increasing prevalence across the age range. The authors dwell on the disease management, exacerbations, care and therapy, taking into account all too often overlooked psychosomatic determinants. Novel markers of pulmonary sarcoidosis, also an inflammatory disease, albeit of unknown etiology, are described. The outstanding lung images of cystic fibrosis are presented in another chapter. Finally, there are reports on the extent of the influenza scourge in Poland during the past 2016/2017 epidemic season. The book is addressed to clinicians, family physicians, medical scholars, and all professionals engaged in the preservation of respiratory health.
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Naturwissenschaften Biowissenschaften Biowissenschaften Neurobiologie, Verhaltensbiologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Physiologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Biomedizin, Medizinische Forschung, Klinische Studien
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Pneumologie, Atmung, Asthma
Weitere Infos & Material
Preface
Coexistence of Chronic Bronchitis in Chronic Obstructive Lung Disease
Filip Mejza, Pawel Nastalek, Agnieszka Mastalerz-Migas, Zbigniew Doniec, and Wojciech Skucha
Influence of Gaseous Pollutants on COPD Exacerbations in Patients with Cardiovascular Comorbidities
Michal Zielinski, Mariusz Gasior, Dariusz Jastrzebski, Aneta Desperak, and Dariusz Ziora
Chemotherapy-Induced Takotsubo Syndrome
Monika Budnik, Jakub Kucharz, Pawel Wiechno, Tomasz Demkow, Janusz Kochanowski, Elzbieta Górska, and Grzegorz Opolski
Blood Group and Incidence of Asthma and Chronic Obstructive Pulmonary Disease
Bozena Mroczek, Zygmunt Sitko, Agnieszka Sujewicz, Weronika Wolinska, Iwona Karpeta-Pawlak, and Donata Kurpas
Satisfaction with Life and Adaptive Reactions in People Treated for Chronic Obstructive Pulmonary Disease
Bartlomiej Drop, Mariola Janiszewska, Agnieszka Baranska, Krzysztof Kanecki, Aneta Nitsch-Osuch, and Magdalena Bogdan
Estimates of Medication Expenditure for Ischemic Heart Disease Accompanying Chronic Obstructive Pulmonary Disease
Edyta Rysiak, Izabela Prokop, Ilona Zareba, and Robert M. Mróz
Proangiogenic and Profibrotic Markers in Pulmonary Sarcoidosis
I. Tuleta, L. Biener, C. Pizarro, G. Nickenig, and D. Skowasch
Congruence between Pulmonary Function and Computed Tomography Imaging Assessment of Cystic Fibrosis Severity
Anna Rybacka, Joanna Gozdzik-Spychalska, Adam Rybacki, Tomasz Piorunek, Halina Batura-Gabryel, and Katarzyna Karmelita-Katulska
Detection of Influenza in the Epidemic Season 2016/2017 Based on I–MOVE+ Project
E. Hallmann-Szelinska, K. Cieslak, K. Szymanski, D. Kowalczyk, M.R. Korczynska, I. Paradowska-Stankiewicz, and L.B. Brydak
Influenza and Influenza-Like Viruses: Frequent Infections in Children under 14 Years of Age during the 2016/2017 Epidemic Season
K. Cieslak, D. Kowalczyk, K. Szymanski, E. Hallmann- Szelinska, and L.B. Brydak
Index
